Sanomedics (SIMH) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access SIMH Annual Balance Sheets →
Changes in quarterly balance sheet trends offer perspective on how Sanomedics balances growth, leverage, and shareholder equity.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2015)
(Jun 30 2015) (Mar 31 2015) (Dec 31 2014) (Sep 30 2014)
Assets
Cash & cash equivalent0.02
Deposit Assets0.01
Cash & Short-term Investments0.00
Accounts receivable0.01
Inventories0.02
Other Prepaid Expense, Current PR0.00
Total Current Assets0.06
Equipment/Property/Plant Net0.02
Intangible Assets0.01
Other Assets, Noncurrent0.00
Total Assets0.09
Liabilities
Accounts Payable and Other Accrued Liabilities, Current0.63
Accrued Liabilities, Current0.48
Derivative Liability, Current DE3.39
Notes Payable, Current NO0.58
Other Liabilities, Current1.85
Total Current Liabilities6.93
Total Long-term Debt0.00
Other liabilities, Noncurrent0.07
Total Liabilities7.00
Stockholders' Equity
Stock Subscription Receivable-
Common Stock Value0.00
Common Stock, Held by Subsidiary etc.-
Additional Paid In Capital Common Stock17.00
Retained Earnings / Accumulated Deficit-23.91
Other Equity0.00
Common Stockholder's Equity-6.91
Preferred Stockholder's Equity0.00
Total Stockholder's Equity-6.91
Liabilities & Stockholder's Equity0.09
4 historic quarters locked

Sign in to unlock the full Sanomedics balance sheet history.

About SIMH Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.